Description:
Lactusan – biologically active additive (BAA); prebiotic. It stimulates the growth of beneficial microflora and restores its own microflora in the colon, protects the beneficial intestinal microflora from antibiotics, inhibits pathogenic microflora, reduces the ingress of toxins into the body, relieves chronic constipation. It is used for intestinal dysbiosis, chronic constipation (including in pregnant women), colitis, allergic diseases; to activate the intestinal immune system.
Properties:
Lactusan is a biologically active additive (BAA), a source of lactulose. Belongs to the class of prebiotic drugs.
Lactusan stimulates the growth of beneficial microflora in the colon and is a powerful bifidogenic drug. Reaching the colon, lactulose becomes an ideal breeding ground for beneficial bifidobacteria and lactobacilli.
Lactusan restores its own microflora. Unlike various kinds of bacterial preparations that populate the large intestine with foreign microflora, lactulose stimulates the development of its own intestinal microbial pool.
When treating with antibiotics, Lactusan protects against the negative effects of antibiotic therapy, protects the beneficial intestinal microflora from the damaging effects of antibiotics.
Lactusan inhibits pathogenic microflora. The metabolic products of bifidobacteria and lactobacilli, which begin to dominate in the large intestine, inhibit the vital activity of pathogenic intestinal bacteria, protect against intestinal candidiasis, etc.
Lactusan relieves chronic constipation. The beneficial microflora of the large intestine, developing under the influence of lactulose, acidifies the intestines, stimulating its peristalsis.
Lactusan reduces the ingress of toxins into the body. The suppression of the pathogenic microflora of the intestine significantly reduces the penetration of neurotoxins and carcinogens into the blood. Reduces stress on the liver by providing intestinal detoxification.
Lactusan can be used in the treatment of liver failure and hepatic encephalopathy, since the reproduction of proteolytic bacteria is suppressed and the formation of nitrogen-containing toxic substances released by the proteolytic flora and playing an important role in the pathogenesis of hepatic encephalopathy is reduced.
Lactusan protects against kidney failure. Under the influence of lactulose, the absorption of ammonia by the large intestine increases and its excretion from the body. Part of nitrogenous toxins, products of protein catabolism, is excreted not through the kidneys, but through the intestines.
Lactusan protects the body from infections. People who regularly take Lactusan are less vulnerable to intestinal infections, as well as lung and genitourinary infections.
Lactusan protects against premature aging by reducing the penetration of toxins into the bloodstream. Protects body cells from poisoning and, thereby, from premature aging.
It has been found that the consumption of Lactusan promotes the absorption of calcium and other minerals.
Recommendations for use:
Lactusan is indicated for:
– intestinal dysbiosis in adults and children of varying severity, incl. to correct the effects of antibiotic therapy (recommended for the correction of intestinal microflora, after antibiotic treatment);
– chronic constipation in the elderly, children, pregnant women, as well as in patients who have been in bed for a long time;
– toxicosis of pregnant women with functional digestive disorders;
– colitis and other diseases of the gastrointestinal tract;
– salmonellosis;
– renal failure;
– diseases of the liver and pancreas of various etiologies (including with cirrhosis of the liver, intrahepatic cholestasis);
– allergic reactions of various origins (atopic dermatitis, urticaria and other dermatoses).
Lactusan is indicated for:– activation of the intestinal immune system;
– protection against intestinal infection;
– prevention of infections of the genitourinary system;
– prevention of colon cancer.
Mode of application:
Lactusan syrup: for adults – 2 teaspoons 2 times a day (10 ml 2 times a day); children – 1 teaspoon 2 times a day (5 ml 2 times a day) with meals, for 7-14 days.
Tablet form of Lactusan: for adults – 4-5 tablets 2 times a day; children over 5 years old – 3 tablets daily with meals with food.
The clinical effect occurs in 2-3 days from the start of taking Lactusan. Duration of admission is 7-14 days. With advanced dysbacteriosis, the duration of taking Lactusan increases by 1.5-2 times.
General healing effect on the aging body: the daily dose of Lactusan should be at least 20 ml of syrup or 4-6 tablets.
Contraindications!
Individual intolerance (including history of hypersensitivity) components of Lactusan, intestinal obstruction, galactosemia, lactase deficiency.
The use of Lactusan is possible in pregnant and lactating mothers (according to the doctor’s recommendation).
In the first days of taking Lactusan, flatulence may appear, which disappears within 3 days. Sometimes there is a laxative effect. In case of an overdose, nausea, abdominal pain and diarrhea are possible, which requires a dose adjustment of Lactusan. If higher doses are used for a long time in the treatment of hepatic encephalopathy, an electrolyte imbalance may develop in a patient due to diarrhea.
If signs of diarrhea appear, the dose of Lactusan should be halved.
Storage conditions and periods:
The storage temperature of the syrup to preserve its pharmacological and physicochemical properties is up to 20 ° C. The drug is suitable for use for 2 years.
Release form:
Bottle with a measuring cup 300 g
This product is not a medical product.
